Clinical Trial: Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title:
Brief Summary: The present study was designed to study the impact of empirical treatment with colistin empirical monotherapy and combined treatment with tigecycline and vancomycin on mortality of bacteremia Multiresistant Acinetobacter Baumannii . The main objective was to evaluate the efficacy of empirical treatment with colistin and combined targeted therapy. The different therapeutical interventions were administered following the routine clinical practice in the medical centre and the investigator did not assign specific interventions to the subjects of the study.
Detailed Summary:
Sponsor: Maimónides Biomedical Research Institute of Córdoba
Current Primary Outcome: All-cause 30-day mortality (crude). [ Time Frame: 30 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome: All-cause 14 day mortality (crude). [ Time Frame: 14 days ]
Original Secondary Outcome: Same as current
Information By: Maimónides Biomedical Research Institute of Córdoba
Dates:
Date Received: August 28, 2015
Date Started: January 2010
Date Completion:
Last Updated: October 8, 2015
Last Verified: October 2015